Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Read the terms carefully
(2021) Cell Rep 36 : 109374-109374 PubMed: 34260945 Search on PubMed DOI: Primary Citation Related Structures: 7KI0, 7KI1 PubMed Abstract: The glucagon-like peptide-1 receptor (GLP-1R) regulates insulin secretion, carbohydrate metabolism, and appetite and is an important target for treatment of type 2 diabetes and obesity
We prioritize data reliability, controlled conditions, and the advancement of best practices in peptide reconstitution and compound stability, supporting precise and reproducible research outcomes
Introduction This study further extends and clarifies the effect of the stable gastric pentadecapeptide BPC 157 on hemostasis [1,2] with addition of N(G)-nitro-L-arginine methylester (L-NAME) and L-arginine and heparin and warfarin in rats
About Fractyl Health Fractyl Health is a clinical-stage metabolic therapeutics company advancing two differentiated candidates designed to target the root causes of obesity and T2D: Revita, a procedural therapy in pivotal development for post-GLP-1 weight maintenance, and Rejuva, an AAV-based gene therapy platform with its lead candidate RJVA-001 entering first-in-human clinical studies
US$ 20.07
US$ 22.21
US$ 23.39
US$ 29.45
US$ 20.23
US$ 26.10
